Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nancy M. Allen LaPointe
Adherence to Guideline Recommendations for Antiarrhythmic Drugs in Atrial Fibrillation
American Heart Journal
Cardiovascular Medicine
Cardiology
What Clinicians Should Know About the QT Interval
JAMA - Journal of the American Medical Association
Medicine
Related publications
Class 1C Antiarrhythmic Drugs in Atrial Fibrillation and Coronary Artery Disease
Journal of Cardiovascular Electrophysiology
Cardiovascular Medicine
Physiology
Cardiology
Antiarrhythmic Drug Therapy for Atrial Fibrillation
Circulation
Cardiovascular Medicine
Physiology
Cardiology
New Antiarrhythmic Drug for the Treatment of Atrial Fibrillation. Study Data, Clinical Guidelines, Regulatory Agency Recommendations
Rational Pharmacotherapy in Cardiology
Cardiovascular Medicine
Pharmacology
Cardiology
The Role of MicroRNAs in Antiarrhythmic Therapy for Atrial Fibrillation
Arrhythmia and Electrophysiology Review
Cardiovascular Medicine
Physiology
Cardiology
Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Symptomatic Atrial Fibrillation
JAMA - Journal of the American Medical Association
Medicine
Failure of Antiarrhythmic Drugs to Prevent Experimental Reperfusion Ventricular Fibrillation
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Managing Atrial Fibrillation: Catheter Ablation or Antiarrhythmic Therapy?
Circulation: Arrhythmia and Electrophysiology
Medicine
Cardiovascular Medicine
Physiology
Cardiology
Effects of E-4031 on Atrial Fibrillation Threhold: A Comparative Study With Class I Antiarrhythmic Drugs.
Japanese Journal of Electrocardiology
Antiarrhythmic Drug Therapy for Atrial Fibrillation in Patients With Left Ventricular Dysfunction
Japanese Journal of Electrocardiology